Could a kidney cell injection slow Diabetes-Related kidney failure?
Disease control
Completed
This study tested an experimental cell therapy called REACT (rilparencel) in 53 adults with type 1 or 2 diabetes and chronic kidney disease. The therapy involves injecting a person's own kidney cells into their kidneys to see if it can slow the loss of kidney function. The goal i…
Phase: PHASE2 • Sponsor: Prokidney • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC